Walleye Capital
ORGS

Walleye Capital’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Walleye Capital’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,803
Closed -$17K – 5647
2023
Q3 		$17K Sell
2,803
-4,321
-61% -$38.7K ﹤0.01% 4408
2023
Q2 		$99K Buy
+7,124
New +$84.4K ﹤0.01% 3438

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Walleye Capital's ORGS Position: Q4 2023 in Review

Walleye Capital sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2023, closing a stake of 2,803 shares — an estimated $17K sold.

Walleye Capital first reported a position in ORGS in Q2 2023 and held it in 2 quarters. The position peaked at $99K in Q2 2023. 19 funds tracked by Wall St. Rank hold ORGS as of Q4 2023.

  • Walleye Capital reported no remaining Orgenesis Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 2,803 Orgenesis Inc. Common Stock shares in Q4 2023, an estimated $17K.
  • Walleye Capital first reported a position in Orgenesis Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Walleye Capital's Orgenesis Inc. Common Stock position peaked at $99K in Q2 2023.
  • 19 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.